| Literature DB >> 26016740 |
Mengmeng Ma1, Benjamin D Anderson2, Tao Wang3, Yingan Chen4, Dingmei Zhang5, Gregory C Gray2, Jiahai Lu6.
Abstract
During July to September 2014, we performed a controlled, cross-sectional, seroepidemiologic study among 203 swine workers and 115 control subjects in Guangdong Province. Sera were tested using a hemagglutination inhibition assay against locally-isolated swine H3N2 and H1N1 viruses and commercially-obtained human influenza viral antigens. We found swine workers had a greater prevalence and odds of seropositivity against the swine H3N2 virus (17.3% vs. 7.0%; adjusted OR, 3.4; 95% CI, 1.1 -10.7). Younger age, self-report of a respiratory illness during the last 12 months, and seropositivity against seasonal H3N2 virus were identified as significant risk factors for seropositivity against swine H3N2 virus. As swine workers in China may be exposed to novel influenza viruses, it seems prudent for China to conduct special surveillance for such viruses among them. It also seems wise to offer such workers seasonal influenza vaccines with a goal to reduce cross-species influenza virus transmission.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26016740 PMCID: PMC4446356 DOI: 10.1371/journal.pone.0128479
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1The locations where participants were enrolled in Guangdong Province, China, July-September 2014.
Guangdong Province is marked with light gray on the map. The two adjoining cities, Zhongshan and Guangzhou, are highlighted with dark gray while other cities in the Pearl River Delta Region are marked with medium gray. Black triangles indicate enrollment sites for control subjects. For swine workers, enrollment sites are marked with a black pushpin. Note that enrollments were sometimes made at several farms under one pushpin.
Demographic and other characteristics of study participants upon enrollment, Guangdong Province, China, July-September 2014.
| Characteristic | Total | Swine workers | Control subjects |
|---|---|---|---|
| (N = 318) | (N = 203) | (N = 115) | |
|
| |||
|
| 218 | 142 (70.0) | 76 (66.1) |
|
| 100 | 61 (30.0) | 39 (33.9) |
|
| |||
|
| 58 | 38 (18.7) | 20 (17.4) |
|
| 79 | 51 (25.1) | 28 (24.3) |
|
| 111 | 71 (35.0) | 40 (34.8) |
|
| 70 | 43 (21.2) | 27 (23.5) |
|
| 318 | 40.2 | 41.2 |
|
| |||
|
| 130 | 130 (64.0) | 0 (0.0) |
|
| 188 | 73 (36.0) | 115 (100.0) |
|
| |||
|
| 106 | 91 (46.7) | 15 (20.0) |
|
| 164 | 104 (53.3) | 60 (80.0) |
|
| |||
|
| 169 | 141 (70.1) | 28 (35.4) |
|
| 76 | 43 (21.4) | 33 (41.8) |
|
| 35 | 17 (8.5) | 18 (22.8) |
|
| |||
|
| 215 | 143 (82.7) | 72 (97.3) |
|
| 32 | 30 (17.3) | 2 (2.7) |
|
| |||
|
| 24 | 13 (6.4) | 11 (13.9) |
|
| 258 | 190 (93.6) | 68 (86.1) |
|
| |||
|
| 31 | 16 (7.9) | 15 (19.0) |
|
| 251 | 187 (92.1) | 64 (81.0) |
|
| |||
|
| 8 | 7 (3.6) | 1 (1.3) |
|
| 267 | 190 (96.4) | 77 (98.7) |
|
| |||
|
| 14 | 5 (2.6) | 9 (11.5) |
|
| 257 | 188 (97.4) | 69 (88.5) |
|
| |||
|
| 10 | 2 (1.0) | 8 (10.4) |
|
| 259 | 190 (99.0) | 69 (89.6) |
|
| |||
|
| 102 | 80 (39.8) | 22 (28.2) |
|
| 177 | 121 (60.2) | 56 (71.8) |
|
| |||
|
| 76 | 63 (31.7) | 13 (16.5) |
|
| 202 | 136 (68.3) | 66 (83.5) |
|
| |||
|
| 12 | 9 (4.8) | 3 (3.9) |
|
| 253 | 180 (95.2) | 73 (96.1) |
|
| |||
|
| 152 | 124 (61.4) | 28 (35.4) |
|
| 129 | 78 (38.6) | 51 (64.6) |
Data are no. (%) of subjects, unless otherwise indicated. Two-sided Chi-square tests or Fisher’s Exact Test were used for dichotomous data, and Independent samples T-test was used for continuous data, unless otherwise indicated.
a Significantly different than control subjects at α = 0.05.
b Variable has some missing data.
c Mann-Whitney U rank sum analysis used.
Hemagglutination inhibition serologic assay results against swine, and human influenza viruses for participants' sera, Guangdong Province, China, July-September 2014.
| Virus | Total | Swine workers | Control subjects | Unadjusted OR |
|---|---|---|---|---|
| (N = 317 | (N = 202) | (N = 115) | (95% CI) | |
|
| no convergence | |||
|
| 1 (0.3) | 1 (0.5) | 0 (0.0) | |
|
| 316 (99.7) | 201 (99.5) | 115 (100.0) | |
|
| 2.8 (1.3–6.3) | |||
|
| 43 (13.6) | 35 (17.3) | 8 (7.0) | |
|
| 274 (86.4) | 167 (82.7) | 107 (93.0) | |
|
| 0.7 (0.3–1.8) | |||
|
| 21 (6.6) | 12 (5.9) | 9 (7.8) | |
|
| 296 (93.4) | 190 (94.1) | 106 (92.2) | |
|
| 1.1 (0.7–1.7) | |||
|
| 102 (32.2) | 66 (32.7) | 36 (32.2) | |
|
| 215 (67.8) | 136 (67.3) | 79 (67.8) |
Data are no. (%) of subjects, unless otherwise indicated. Two-sided Chi-square tests or Fisher’s Exact Test were used for dichotomous data analysis.
a Hemagglutination inhibition assay, negative = titer <1:40, positive = titer ≥1:40.
b 317 sera were available from the 318 study participants.
c Unadjusted odds ratio was calculated from bivariate analysis with binary logistic regression method for swine workers versus control subjects.
d Indicates data were too sparse for the model to converge.
Geometric mean titers (reciprocal shown) of antibodies against swine, human and avian influenza viruses for participants' sera, Guangdong Province, China, July-September 2014.
| Study Population | Geometric mean titer, by virus | ||||
|---|---|---|---|---|---|
| Swine | Swine | Pandemic | Seasonal | Avian | |
| H1N1 | H3N2 | H1N1 | H3N2 | H9 | |
|
| 5.30 | 10.42 | 6.27 | 14.84 | 5.05 |
|
| 5.00 | 7.76 | 7.44 | 13.60 | 5.03 |
Data not shown for avian H5 and H7 (all negative).
a For GMTs calculation [26], negative titers were assigned the value of half the minimum detectable titer (1:5) and titers greater than the final dilution were assigned the value of twice the largest titer (1:640).
b The geometric mean titers (GMTs) for swine workers were found to differ from those for control subjects at α = 0.05 by Mann-Whitney U rank sum analysis.
Risk factors for elevated antibodies against swine H3N2 virus, using unconditional logistic regression modeling, among study participants, Guangdong Province, China, July-September 2014.
| Variables | Total No. | No. (%) | Unadjusted OR | Adjusted OR |
|---|---|---|---|---|
| (95% CI) | (95% CI) | |||
|
| ||||
|
| 202 | 35 (17.3) | 2.8 (1.3–6.3) | 3.4 (1.1–10.7) |
|
| 115 | 8 (7.0) | Reference | Reference |
|
| ||||
|
| 70 | 2 (2.9) | 0.0 (0.0–0.2) | 0.1 (0.0–0.3) |
|
| 111 | 7 (6.3) | 0.1 (0.0–0.2) | 0.1 (0.0–0.3) |
|
| 79 | 10 (12.7) | 0.2 (0.1–0.5) | 0.2 (0.1–0.5) |
|
| 57 | 24 (42.1) | Reference | Reference |
|
| ||||
|
| 151 | 31 (20.5) | 3.0 (1.4–6.5) | 3.2 (1.2–8.2) |
|
| 128 | 10 (7.8) | Reference | Reference |
|
| ||||
|
| 21 | 8 (38.1) | 4.6 (1.8–11.9) | 3.5 (0.9–13.1) |
|
| 296 | 35 (11.8) | Reference | Reference |
|
| ||||
|
| 102 | 29 (28.4) | 5.7 (2.9–11.4) | 4.8 (2.2–10.8) |
|
| 215 | 14 (6.5) | Reference | Reference |
|
| ||||
|
| 31 | 1 (3.2) | 0.2 (0.0–1.3) | - |
|
| 250 | 40 (16.0) | Reference | |
|
| ||||
|
| 129 | 23 (17.8) | 1.8 (1.0–3.5) | - |
|
| 188 | 20 (10.6) | Reference | |
|
| ||||
|
| 214 | 25 (11.7) | 0.5 (0.2–1.2) | - |
|
| 32 | 7 (21.9) | Reference | |
Data are no. (%) of subjects with elevated antibodies against swine H3N2 virus within levels of each covariate, unless otherwise indicated.
a Significantly different than control subjects at α = 0.05.
b Variable has some missing data.
c Hemagglutination inhibition assay, negative = titer < 1:40, positive = titer ≥ 1:40.